IGM Biosciences, Inc. (29)

Browse by Contract Category

Contracts

Form of Pre-Funded Warrant (Filed With SEC on December 9, 2020)
Amended and Restated 2018 Omnibus Incentive Plan, amended July 30, 2020 and forms of agreements thereunder (Filed With SEC on November 5, 2020)
Description of Securities (Filed With SEC on March 26, 2020)
Form of Indemnification Agreement, by and between the Registrant and each of its directors and executive officers (Filed With SEC on September 3, 2019)
Lease by and between Real Property Investments, LLC and the Registrant, dated February 27, 2019 (Filed With SEC on August 19, 2019)
Underwriting Agreement, dated as of December 8, 2020, by and among the Company and the Representatives (Filed With SEC on December 9, 2020)
Form of Registration Rights Agreement, by and between the Registrant and certain securityholders (Filed With SEC on December 7, 2020)
Amended and Restated 2019 Employee Stock Purchase Plan, amended July 30, 2020 and forms of agreements thereunder (Filed With SEC on November 5, 2020)
Amended and Restated 2018 Omnibus Incentive Plan (Filed With SEC on August 3, 2020)
Amended and Restated 2019 Employee Stock Purchase Plan (Filed With SEC on August 3, 2020)
Outside Director Compensation Policy (as amended and restated on February 5, 2020) (Filed With SEC on March 26, 2020)
Specimen common stock certificate of the Registrant (Filed With SEC on September 3, 2019)
Form of Underwriting Agreement (Filed With SEC on September 3, 2019)
2018 Omnibus Incentive Plan and forms of agreements thereunder (Filed With SEC on September 3, 2019)
Amended and Restated 2018 Omnibus Incentive Plan and forms of agreements thereunder, to be in effect upon completion of this offering (Filed With SEC on September 3, 2019)
2019 Employee Stock Purchase Plan and forms of agreements thereunder, to be in effect upon completion of this offering (Filed With SEC on September 3, 2019)
Outside Director Compensation Policy (Filed With SEC on September 3, 2019)
Restricted Stock Grant Agreement, by and between Daniel Chen and the Registrant, dated as of December 30, 2018 (Filed With SEC on August 19, 2019)
Amended and Restated 2010 Stock Plan and forms of agreement thereunder (Filed With SEC on August 19, 2019)
Amended and Restated Investor Rights Agreement, by and among the Registrant and certain of its stockholders, dated as of June 28, 2019 (Filed With SEC on August 19, 2019)
Confirmatory Employment Letter, by and between Fred Schwarzer and the Registrant, effective as of August 19, 2019 (Filed With SEC on August 19, 2019)
Confirmatory Employment Letter, by and between Bruce Keyt and the Registrant, effective as of August 19, 2019 (Filed With SEC on August 19, 2019)
Nominating Agreement, by and among Redmile Biopharma Investments II, L.P., RAF, L.P., Redmile Strategic Master Fund, LP and the Registrant, dated as of June 28, 2019 (Filed With SEC on August 19, 2019)
Nominating Agreement, by and between Haldor Topse Holding A/S and the Registrant, dated as of June 28, 2019 (Filed With SEC on August 19, 2019)
Nominating Agreement, by and among 667, L.P., Baker Brothers Life Sciences, L.P. and the Registrant, dated as of June 28, 2019 (Filed With SEC on August 19, 2019)
Executive Incentive Compensation Plan (Filed With SEC on August 19, 2019)
Employment Agreement, by and between Daniel Chen and the Registrant, dated as of July 12, 2018 (Filed With SEC on August 19, 2019)
Confirmatory Employment Letter, by and between Misbah Tahir and the Registrant, effective as of August 19, 2019 (Filed With SEC on August 19, 2019)
Change in Control and Severance Policy (Filed With SEC on August 19, 2019)